61703-39-7 Usage
General Description
L-1-Cbz-pipecolinamide, also known as L-1-(benzyloxycarbonyl)pipecolinamide, falls within the family of the N-protected amino acids and derivatives. It is significant for its applications in organic synthesis and pharmaceutical processes. This specific compound, nuanced with a chiral center at the alpha-carbon, involves a synthetic approach for producing relevant chemicals. While the detailed characteristics such as melting point, boiling point, its structure and interactions with other chemicals may vary, they need to be appropriately researched. Its specific set of characteristics signifies its particular usage and value within different areas of chemical synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 61703-39-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,7,0 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 61703-39:
(7*6)+(6*1)+(5*7)+(4*0)+(3*3)+(2*3)+(1*9)=107
107 % 10 = 7
So 61703-39-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H18N2O3/c15-13(17)12-8-4-5-9-16(12)14(18)19-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10H2,(H2,15,17)/t12-/m0/s1
61703-39-7Relevant articles and documents
PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS
-
Page/Page column 112, (2009/06/27)
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischaemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes mellitus, neurodegenerative diseases, retroviral infections, retinaldamage, skin senescence and UV-induced skin damage, and as chemo-or radiosensitizers for cancer treatment.
